The global battle against SARS-CoV-2 and COVID-19 at the third year DOI Creative Commons
Chu‐Xia Deng

International Journal of Biological Sciences, Journal Year: 2022, Volume and Issue: 18(12), P. 4792 - 4794

Published: Jan. 1, 2022

Since the outbreak of Coronavirus Disease-19 (COVID-19) pandemic at end 2019, SARS-CoV-2 has spread to over 228 countries and territories, infected least 561,281,981, caused more than 6,373,902 deaths as today (July 12, 2022) [1].In January 2022, reached its highest level with infection rate mounting up 3 million per day for nearly one entire month.It gradually dropped about 500,000 in middle May, but increased recent weeks.Meanwhile, daily declined from 12,000 cases 1,500 today.However, weeks, Omicron BA.4 BA.5 become dominant, although currently no evidence suggested that they could cause severe illnesses previous variants.Thus, COVID-19 is far away over, even we have gained some experiences reducing devastating effects disease.During past two half years, International Journal Biological Sciences published 2 special issues focusing on March 2020 [2] April 2021 [3], respectively.In present issue, organized 17 articles share authors' understanding various angles.Kwok 1 discussed roles nucleic acid-based, antigen-based, antibody-based diagnostic tests first line defense fighting against COVID-19, considerations how Kwok HF.The significance advanced testing control measures.

Language: Английский

The global battle against SARS-CoV-2 and COVID-19 at the third year DOI Creative Commons
Chu‐Xia Deng

International Journal of Biological Sciences, Journal Year: 2022, Volume and Issue: 18(12), P. 4792 - 4794

Published: Jan. 1, 2022

Since the outbreak of Coronavirus Disease-19 (COVID-19) pandemic at end 2019, SARS-CoV-2 has spread to over 228 countries and territories, infected least 561,281,981, caused more than 6,373,902 deaths as today (July 12, 2022) [1].In January 2022, reached its highest level with infection rate mounting up 3 million per day for nearly one entire month.It gradually dropped about 500,000 in middle May, but increased recent weeks.Meanwhile, daily declined from 12,000 cases 1,500 today.However, weeks, Omicron BA.4 BA.5 become dominant, although currently no evidence suggested that they could cause severe illnesses previous variants.Thus, COVID-19 is far away over, even we have gained some experiences reducing devastating effects disease.During past two half years, International Journal Biological Sciences published 2 special issues focusing on March 2020 [2] April 2021 [3], respectively.In present issue, organized 17 articles share authors' understanding various angles.Kwok 1 discussed roles nucleic acid-based, antigen-based, antibody-based diagnostic tests first line defense fighting against COVID-19, considerations how Kwok HF.The significance advanced testing control measures.

Language: Английский

Citations

1